Pathogenic variants of BRCA1 and BRCA2 only explain the genetic cause of approximately 10% of hereditary breast and ovarian cancers (transmitted to offspring), underscoring the clinical importance of testing other DNA repair genes (41). Here, BRCA2 is linked to ovarian cancer.